Paras Healthcare IPO
Market Sentiment
IPO Details
IPO Reservation
Financial Analysis
Financial Data
Financial Performance
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 1,151.02 | 1,314.21 | 1,628.78 |
| Expense | 1,144.39 | 1,364.24 | 1,552.75 |
| Profit (PAT) | 15.33 | 57.98 | 43.83 |
| Total Assets | 1,477.66 | 1,810.45 | 2,071.14 |
Peer Comparison
| Company | EPS | P/E | RoNW % | NAV | Income |
|---|---|---|---|---|---|
| Aster DM Healthcare Limited | 7.53 | 95.90 | 9.70 | 88.32 | 4,643.22 Cr |
| Apollo Hospitals Enterprise Limited | 135.04 | 60.02 | 21.95 | 657.58 | 25,228.50 Cr |
| Fortis Healthcare Limited | 13.80 | 67.31 | 11.08 | 131.07 | 9,127.84 Cr |
| Global Health Limited | 20.71 | 56.55 | 15.15 | 147.06 | 4,410.30 Cr |
| Jupiter Lifeline Hospitals Limited | 29.59 | 43.98 | 13.41 | 235.50 | 1,499.79 Cr |
| Krishna Institute of Medical Sciences Limited | 6.03 | 124.98 | 11.01 | 56.17 | 3,904.60 Cr |
| Max Healthcare Institute Limited | 14.83 | 63.59 | 14.33 | 109.53 | 8,373.45 Cr |
| Narayana Hrudayalaya Limited | 39.67 | 48.00 | 19.74 | 222.02 | 7,896.04 Cr |
| Yatharth Hospital and Trauma Care Services Limited | 18.20 | 43.56 | 10.36 | 184.79 | 1,207.17 Cr |
Strengths & Risks
- Revenue grew 24% in the latest reported year.
- Thin profit margin — 2.7%.
- Elevated leverage — debt/equity of 3.53.
- Largely an offer for sale — most proceeds go to selling shareholders, not the company.
Compiled from this issue's live GMP, subscription, valuation and financial data, and updated as those figures change. Informational only — not investment advice. Always read the RHP before applying.
Company Information
About Paras Healthcare
Paras Healthcare Limited, founded in 1987, is the fifth-largest healthcare provider across North India, Bihar, and Jharkhand. As of now, the company runs 8 hospitals under the Paras Health brand in North India, including Gurugram, Haryana, Patna, Bihar, Uttar Pradesh, Udaipur, Rajasthan, Jharkhand, and Jammu and Kashmir. The main goal of the company is to offer high-quality and affordable healthcare in tier 2 and tier 3 cities. Heart care, cancer treatment, brain and nerve care, digestive health, and bone and joint replacement are the variety of medical services the company offers. Paras Healthcare has established its presence among customers by having 18 years of experience in the healthcare industry. In March 2022, the company had a bed capacity of 1250 beds, which expanded to 2135 in March 2024. Moreover, the company consists of a dedicated team of 1091 doctors and 1509 nurses throughout its hospitals as of March 31, 2024.
Company Contact Information
Paras Healthcare Limited, 1 st Floor, Tower B, Paras Twin Towers,, Golf Course Road, Sector 54,, Gurugram – 122002, Haryana, India
Objects of the Issue
| Purpose | Amount (Cr) |
|---|---|
| Prepayment or scheduled re-payment, in full or part, of certain outstanding borrowings availed by the Company | 320.90 |
| Investment in the wholly owned Subsidiary, PMHPL (which also operates the hospital in Srinagar), for repayment/prepayment of borrowings, in full or part, of PMHPL | 54.10 |
| General Corporate Purpose | - |
Resources & Documents
IPO Documents
Draft Red Herring ProspectusParas Healthcare IPO - Quick Take
Paras Healthcare is preparing a mainboard offering for an issue size of Rs 1,800 crore. The Mainboard issue is in the upcoming pipeline with dates yet to be finalised.
The issue is promoted by Dr. Dharminder Kumar Nagar with JM Financial Limited, BofA Securities India Limited, Nuvama Wealth Management Limited acting as lead manager. Net proceeds will primarily be used towards prepayment or scheduled re-payment, in full or part, of certain outstanding borrowings availed by the Company (Rs 321 crore) and investment in the wholly owned Subsidiary, PMHPL (which also operates the hospital in Srinagar), for repayment/prepaymen… (Rs 54 crore).
On fundamentals, the company is posting revenue growth of 23.9%, a profit margin of 2.7%, return on equity of 13.0% in its most recent reported period. Listed peers in this segment include Aster DM Healthcare Limited (P/E 95.90x) and Apollo Hospitals Enterprise Limited (P/E 60.02x) — useful reference points when evaluating the issue's pricing relative to where the broader sector is trading.
All figures below — GMP history, subscription tiers, financials and peers — are aggregated from public disclosures. Always apply through your own broker after reading the RHP.
Frequently Asked Questions
Paras Healthcare IPO GMP — What It Means
GMP is an unofficial, dealer-quoted figure that hints at expected listing-day demand — it is not a guaranteed listing price. For Paras Healthcare it should be read alongside the subscription numbers and the company's fundamentals, since grey-market premiums can swing sharply during the bidding window.
See the full Paras Healthcare GMP history and trend, or learn how grey market premium works and how reliable it is.
Related IPO
Same sector or same stage as Paras Healthcare
No comments yet. Be the first to share your opinion!